Post-approval studies (Phase 4)Active Not RecruitingNCT05284747
What this trial is testing
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Who this might be right for
Cardiovascular DiseaseMyocardial InfarctionStroke+1 more
Amgen 6,019
Showing 20 of 0 results